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Subregional Localization of the Gene(s) Governing the Human Interferon Induced Antiviral State in Man
SUMMARY
A dosage effect of chromosomal translocation was used to locate the gene(s) which codes for the human interferon induced antiviral state on the long arm of chromosome 2I.
Using mouse-human somatic hybrid cells, Tan, Tischfield & Ruddle (1973) assigned the gene(s) which codes for the human interferon (HIF) induced antiviral state (AVS) to chromosome 2I. Presently, it is not clear if the product of this gene assignment is the putative antiviral protein, the putative receptor site(s) for HIF, or both (Chany et al. J975; Tan, I975) . Nevertheless, the assignment has been confirmed by the dosage effect of chromosome 21 on the inducibility of the AVS in human cells (Tan et al. 1974; Tan, I975) . In this paper we report localization of the gene(s) in question to the long arm of chromosome 21 by measuring the dosage effect of translocated chromosome 21 on the inducibility of the AVS in human cells.
Four human skin fibroblast lines with translocated chromosomes were used. (i) A diploid fibroblast line (t4-2I) in which one of its two chromosomes 21 is translocated to the short arm of chromosome 4 (Seabright et al. 1975) . The translocation results in the deletion of the short arm of chromosome 2~. (ii) A trisomic 2I fibroblast line (t6-zx) in which one of its three chromosomes 21 is translocated to the short arm of chromosome 6. The translocation also results in the deletion of the short arm of chromosome 2I (Borganker, Greene & Coriell, I974) . (iii) A diploid cell line (t2-4), kindly supplied by Dr P. Bowen, University of Alberta, in which a part of chromosome 2 is translocated to chromosome 4. (iv) A trisomic 2I cell line (tI-I7) in which chromosome I is translocated to chromosome I7 (Chapelle et al. 1975) . In addition to these lines, eight trisomic 2I (Y-2I), ten normal diploid (D-21), one monosomic 2I (M-zI) and one trisomic I8 (T-I8) lines of skin fibroblasts were used.
These fibroblast cultures were individually treated with various amounts of human leucocyte interferon. Two preparations were used: (I) one provided by Dr J. Valenta, Smith Kline & French, and partially purified on a Sephadex G-75 column to asp. act. of approx. 4 × lO5 NIH reference units/rag protein (SKF-HIF), and (2) the NIH leucocyte interferon reference reagent, code Go23-9o 1-527 (NIH-HIF). The inducibility of the AVS was assessed in terms of the amount of HIF required to inhibit vesicular stomatitis virus (VSV) RNA synthesis in these cells by 5o ~ (Tan, 1975) . When a given cell line was tested in turn with each interferon preparation, it was found that some 6 to 8 times more units of the NIH reagent interferon than of the SKF preparation seemed consistently to be needed for 5o ~o inhibition of VSV-RNA synthesis (the reasons for this were not investigated, but presumably reflect assay standardization problems). However, when different cell lines were compared the relative number of units of each type of interferon preparation required for 50 %o inhibition were closely comparable, as shown in Table I . The results in this~table show that the t4-21 cells required about the same amount of HIF as D-21 cells whereas t6-21 cells required about the same amount of HIF as T-2I to induce the AVS. Previously, it has been shown (Tan, 1975) that the inducibility of the AVS in human cells is related to the number of chromosomes 2~ present in the cell. According to this finding, one would expect the t4-21 Table I favour the hypothesis that the gene(s) for the induction of the AVS is on the long arm of chromosome z~. The translocated piece of chromosome 2i in the t6-2~ cells was cytogenetically verified (a routine examination performed at the cell repository at Camden) to consist of most of the long arm of this chromosome, as previously reported by Borganker et al. 0974) . The fact that this translocated portion contributed to a chromosome 2I dosage effect on the inducibility of the AVS by HIF in these cells indicates that the gene(s) for AVS is located within its limits. It is unlikely that the dosage effect is the result of a non-specific translocated condition, or an addition of a human chromosome other than chromosome 2I because the T-zl(t~-t7) line and the T-18 line as well as the D-z1(t2-4) line required about the same amounts of HIF to be induced as the T-21 and D-2I lines, respectively (Table I) . The translocated T-21 (t-17) cells have three copies of chromosome 2I, and the T-t8 cells and the t2-4 cells have two copies of chromosome 2i. In view of these considerations we wish to suggest that the gene(s) governing the inducibility of the AVS is on the long arm of chromosome 21. 
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A gene dosage effect on a gene product has also been shown between chromosome 16 and adenine phosphoribosyl transferase (Marimo & Gianelli, 1975) as well as between superoxide dismutase (cytosol form) and chromosome 21 (Sichitiu et aL 1974) . Undoubtedly, chromosome dosage effects on a variety of other assigned gene products will be reported in the near future. It should then be feasible to consider the use of translocated chromosomal dosage for the sub-regional mapping of other genetic markers on to human chromosomes. One obvious limitation with this technique is the availability of naturally occurring translocations. However, such limitations can possibly be resolved by generating appropriate chromosomal deletions by the microbeam laser-irradiation technique of Berns (1974) . These artificially generated deletions, in turn could be used for mapping studies by measuring the dosage effects of these deletions on a specific gene product. 
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